Medexus Pharmaceuticals Inc Sustainability Reports
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company focused on the licensing, development, and commercialization of innovative and rare disease treatment solutions. Its product portfolio spans therapeutic areas such as hematology, hemato-oncology, rheumatology, and allergy within the North American market.
Sector: Manufacturing
Country: Canada
Exchange: Toronto Stock Exchange
LEI: 8945002TBEYY0HLH1M19
FIGI: BBG0029BPRG7
12 reports from 2021 to 2026
- Medexus Pharmaceuticals Inc 2026 Supply Chains Act Report
- Medexus Pharmaceuticals Inc 2026 Consolidated Financial Statements
- Medexus Pharmaceuticals Inc 2026 Consolidated Financial Statements
- Medexus Pharmaceuticals Inc 2025 Consolidated Financial Statements
- Medexus Pharmaceuticals Inc 2025 Consolidated Financial Statements